Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

François Poumeaud, Mathilde Morisseau, Luc Cabel, A. Gonçalves, Catherine Rivier, Olivier Trédan, E. Volant, Jean‐Sébastien Frenel, Sylvain Ladoire, William Jacot, Mathieu Jamelot, Herve Foka Tichoue, Anne Patsouris, Luís Teixeira, François‐Clément Bidard, D. Loirat, M Brunet, C. Lévy, Caroline Bailleux, B. Cabarrou, Antoine Deleuze, L. Uwer, E. Deluche, T. Grellety, Camille Franchet, Frédéric Fiteni, H. Bischoff, Roman Vion, Martina Pagliuca, B. Verret, Stéphanie Bécourt, Thibaut Reverdy, Alexandre de Nonneville, F. Dalenc